Serum IL-18 levels in tuberculosis: Comparison with pneumonia, lung cancer and healthy controls

Respirology

Volumn 10, Issue 3, 2005, Pages 295-299

  Akgun, Metin ^a,b   Saglam, Leyla ^a   Kaynar, Hasan ^a   Yildirim, A Kadir ^a   Mirici, Arzu ^a   Gorguner, Metin ^a   Meral, Mehmet ^a   Ozden, Kemalettin ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b Gogus Hastaliklari Klinigi   (Turkey)

Author keywords

Interleukin 18; Lung cancer; Pneumonia; Tuberculosis

Indexed keywords

INTERLEUKIN 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; LUNG CANCER; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; SPUTUM ANALYSIS; SPUTUM CULTURE; SPUTUM SMEAR;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-18; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONIA; RADIOGRAPHY, THORACIC; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 22644445450     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00710.x     Document Type: Article

References (27)

1. Snider DE Jr, Roper WL. The new tuberculosis. N. Engl. J. Med. 1992; 326: 703-5.
2. Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, van Der Poll T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 1999; 115: 110-13.
3. Yamada G, Shijubo N, Shighara K, Okamura H, Kurimoto M, Abe S. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am. J. Respir. Crit. Care Med. 2000; 161: 1786-9.
4. Nakamura K, Okamura H, Nagata K, Komatsu T, Tamaura T. Purification of a factor which provides a costimulary signal for gamma interferon production. Infect. Immun. 1993; 61: 64-70.
5. Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 1998; 70: 281-312.
6. Dinarello CA. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 1999; 103: 11-24.
7. Barnes PF, Wizel B. Type 1 cytokines and the pathogenesis of tuberculosis. Am. J. Respir. Crit. Care Med. 2000; 161: 1773-4.
8. Flyn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993; 178: 2249-54.
9. Sugawara I. Interleukin 18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens. Microbes Infect. 2000; 2: 1257-63.
10. Billiau A. Interferon γ: biology and role in pathogenesis. Adv. Immunol. 1996; 62: 61-130.
11. Shigehara K, Shijubo N, Ohmichi M et al. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 2000; 162: 1979-82.
12. Shigehara K, Shijubo N, Ohmichi M et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J. Immunol. 2001; 166: 642-9.
13. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pneumonia infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin. Diagn. Lab. Immunol. 2000; 7: 909-14.
14. Tanaka H, Narita M, Teramoto S et al. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae in adults. Chest 2002; 121: 1493-7.
15. Forlani S, Ratta L, Bulgheroni A et al. Cytokine profile of broncho-alveolar lavage in BOOP and UIP. Sarcoidosis Vasc. Diffuse Lung Dis. 2002; 19: 47-53.
16. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin 18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001; 12: 53-72.
17. Fassbender K, Mielke O, Bertsch T et al. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology 1999; 53: 1104-6.
18. Lu H, Yang X, Takeda K et al. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity. Mol. Med. 2000; 6: 604-12.
19. Lauw FN, Branger J, Florquin S et al. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol. 2002; 168: 372-8.
20. Takeda K, Tsutsui H, Yoshimoto T et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998; 8: 383-90.
21. Kawabata T, Ichikura T, Majima T et al. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer 2001; 92: 2050-5.
22. Matsumoto M, Seya T, Kikkawa S et al. Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton. Int. Immunopharmacol. 2001; 1: 1559-69.
23. Street SE, Trapani JA, MacGregor D, Smyth MJ. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J. Exp. Med. 2002; 196: 129-34.
24. Singh SM, Yanagawa H, Hanibuchi M, Miki T, Okamura H, Sone S. Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12. Int. J. Immunopharmacol. 2000; 22: 35-43.
25. Iwasaki T, Yamashita K, Tsujimura T et al. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice. J. Immunother. 2002; 25 (Suppl. 1): S52-60.
26. Dlugovitzky D, Torres-Morales A, Rateni L et al. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol. Med. Microbiol. 1997; 18: 203-7.
27. Van der Kuyp F. The microbiology of the mycobacteria. In: Fishman AP (ed.) Fishman's Pulmonary Diseases and Disorders. McGraw-Hill Co., New York, 1998; 2441-5.